The purpose of this study is to identify health management concerns and needs of family members of asymptomatic and symptomatic persons with mutation in the gene for Huntington Disease (HD).

Condition	Treatment or Intervention	Phase
Huntington Disease	Gene Transfer: Mutation in the gene	Phase III

This is a Phase III study. In Phase 1, focus groups consisting of family members of persons with HD Gene mutation will be conducted and data collected to be analyzed through content analysis to identify salient themes and key issues. In Phase 2, a survey instrument will be developed and field-tested in order to describe the health care needs, management strategies, and needs for health and social services of relative/significant others of asymptomatic and symptomatic persons with the mutation in the gene for HD. In Phase 3, the survey will be distributed to family members of asymptomatic and symptomatic persons with mutation in the gene for HD and frequencies and comparisons of survey responses according to respondent characteristics will be reported.

Genders Eligible for Study:  Both

Criteria

• Family members of asymptomatic and symptomatic persons with mutation in the gene for Huntington Disease

Iowa
      Iowa University College of Nursing, Iowa City,  Iowa,  52242,  United States; Recruiting

Study ID Numbers:  1-R01-NR007970-01
Record last reviewed:  January 2004
Record first received:  January 2, 2004
ClinicalTrials.gov Identifier:  NCT00075140
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-11-08